Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-22-039677
Filing Date
2022-06-28
Accepted
2022-06-28 19:08:38
Documents
1
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4353
  Complete submission text file 0001209191-22-039677.txt   5834
Mailing Address C/O MEDIVATION, INC. 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105
Business Address
BLICKENSTAFF KIM D (Reporting) CIK: 0001238913 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39351 | Film No.: 221051391

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations